Clinical Trial Update: A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children [Phase 2]

View source ↗

Summary

Phase 2 study evaluating two doses of the WRAIR Dengue Vaccine given six months apart in healthy adults and children completed. Results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever
• Dengue Hemorrhagic Fever
• Dengue Shock Syndrome

Drugs mentioned

• WRAIR Dengue Vaccine

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Dengue Fever, Dengue Hemorrhagic Fever | Phase 2 | Status: COMPLETED | Results posted: 2017-06-06